HillsB.A., ButlerB.D., BarrowR.E.Boundary lubrication imparted by pleural surfactants and their indentification.J Appl Physiol1982; 53: 463–9.
2.
GrahameG.R., TorchiaM.G., DankewichK.A., FergusonI.A.Surface-active material in peritoneal effluent on CAPD patients.Perit Dial Bull1985; 5: 109–11.
3.
Di PaoloN., BuoncristianiU., GaggiottiE., CapotondoL., De MiaM.Improvement of impaired ultrafiltration after addition of phosphatidylcholine in patients on CAPD.Perit Dial Bull1986; 6: 44–5.
4.
Di PaoloN., BuoncristianiU., CapotondoL.Phosphatidylcholine and peritoneal transport during peritoneal dialysis.Nephron1986; 44: 365–70.
5.
BreborowiczA., SombolosK., RodelaH., OgilvieR., BargmanJ., OreopoulosD.Mechanism of phosphatidylcholine action during peritoneal dialysis.Perit Dial Bull1987; 7: 6–9.
6.
DobbieJ.W., PavlinaT., LloydJ., JohnsonR.C.Phosphatidylcholine synthesis by peritoneal mesothelium: Its implications for peritoneal dialysis.Am J Kidney Dis1988; 12: 31–6.
7.
DobbieJ.W., LloydJ.K.Mesothelium secretes lamellar bodies in a similar manner to type II pheumocyte secretion of surfactant.Perit Dial Int1989; 9: 215–9.
8.
KrackG., ViglinoG., CavalliP.L.Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in CAPD patients.Perit Dial Int, 1992; 12: 359–64.
9.
Di PaoloB., ChakrabartiE., MaherJ.F.Phosphatidylcholine does not affect peritoneal transport of intact rabbits.Perit Dial Int1989; 9: 211–3.
MactierR.A., KhannaR., TwardowskiZ.L., MooreH., NolphK.D.Influence of phosphatidylcholine on lymphatic absorption during peritoneal dialysis in therat.Perit Dial Int1988; 8: 179–86.
12.
MaherJ.F., HirszelP., HohnadelD.C., AbrahamJ., LasrichM.Fatty acid removal during peritoneal dialysis: Mechanisms, rates and significance.ASAIO1978; 1: 8–14.
13.
Di PaoloN., SacchiG., VanniL.Implant of autologous mesothelial cells in animals and a peritoneal dialysis patient.Int J Artif Organs1989; 12: 485–501.
14.
GotloibL., ShustakA., JaichenkoJ.Loss of mesothelial electronegative fixed charges during murine septic peritonitis.Nephron1989; 51: 77–83.
15.
ChanH., AbrahamG., OreopoulosD.G.Orallecithin improves ultrafiltration in patients on peritoneal dialysis.Perit Dial Int1989; 9: 203–5.
16.
WilliamsJ.D., BeavisJ.M.Phosphatidylcholine and peritoneal dialysis. In: ColesG.A., DaviesM., WilliamsJ.D., eds. CAPD: host defence, nutrition and ultrafiltration.Contrib Nephrol1990; 85: 142–9.
17.
StruijkD.G., vander ReijdenH.J., KredietR.T., KoomenG.C.M., AriszL.Effect of phosphatidylcholine on peritoneal transport and lymphatic absorption in a CAPD patient with sclerosing peritonitis.Nephron1989; 51: 577–8.
18.
QuerquesM., ProcacciniD.A., PappaniA., StrippoliP., PassioneA.Influence of phosphatidylcholine on ultrafiltration and solute transfer in CAPD patients.ASAIO Trans1990; 36: M581–3.
19.
RozgaJ., AnderssonR., SrinivasU., AhrenB., BengmarkS.Influence of phosphatidylcholine on intra-abdominal adhesion formation and peritoneal macrophages.Nephron1990; 54: 134–8.
20.
Ar'Rajab, AhrenB., RozgaJ., BengmarkS.Phosphatidylcholine prevents postoperative peritoneal adhesions: An experimental study in the rat.J Surg Res1991; 50: 212–5.
21.
De VecchiA., CastelnovoC., GuerraL., ScalamognaA.Phosphatidylcholine administration in continuous ambulatory peritoneal dialysis (CAPD) patients with reduced ultrafiltration.Perit Dial Int1989; 9: 207–10.